School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China
Search for other papers by Xinyuan Zhang in
Google Scholar
PubMed
Search for other papers by Suiyan Li in
Google Scholar
PubMed
Search for other papers by Hongwei Liu in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
.001 Waist-to-hip ratio 0.82 ± 0.06 0.84 ± 0.07 <0.001 <0.001 F-G score 0.25 ± 0.74 1.72 ± 2.04 <0.001 <0.001 Acne grade score 0.14 ± 0.34 0.65 ± 0.89 <0.001 <0.001 SBP (mm Hg) 112.59 ± 11.23 114.25 ± 10
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Anna C van der Burgh in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Samer R Khan in
Google Scholar
PubMed
Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Search for other papers by Ewout J Hoorn in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Layal Chaker in
Google Scholar
PubMed
low-normal: 88 (33.8) T low: 112 (43.1) CKD stage 5 definition N.R. 76 (29.2) N.A. Grossman M, Clinical Endocrinology , 2015 T intermediate: 5.0–11.9 nmol/L T low: < 5.0 nmol/L T intermediate: 70 (49.0) T low: 16 (11.2) CKD stage 3–4
Search for other papers by Amar Osmancevic in
Google Scholar
PubMed
Search for other papers by Kristin Ottarsdottir in
Google Scholar
PubMed
Search for other papers by Margareta Hellgren in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
Search for other papers by Bledar Daka in
Google Scholar
PubMed
, independent of confounders (OR 2.03, 95% CI 1.34 to 3.06, P = 0.001 and OR 1.80, 95% CI 1.16–2.78, P = 0.008). The magnitude of the effect was observed to be lower when adjusting for BMI in all fully adjusted models although the same direction in the
Search for other papers by Michael C Velarde in
Google Scholar
PubMed
Search for other papers by Mikaela Erlinda M Bucu in
Google Scholar
PubMed
Search for other papers by Maria Antonia E Habana in
Google Scholar
PubMed
-to-severe cases of endometriosis with revised American Fertility Society (rAFS) scores of III–IV at the time of surgery (adjusted odds ratio (aOR): 10.87, 95% CI: 4.34–27.21, P < 0.001, n = 368) and a 4.1 times higher presence of ovarian endometriomas on
Search for other papers by Silvia Ciancia in
Google Scholar
PubMed
Search for other papers by Vanessa Dubois in
Google Scholar
PubMed
Search for other papers by Martine Cools in
Google Scholar
PubMed
idea of direct androgen action on the bone ( 34 , 35 , 36 , 37 ). A cross-sectional study performed in 199 healthy boys aged 6–19 years confirmed that estrogens are positively associated with bone mineralization (estimated by both aBMD and vBMD
Search for other papers by Estelle Bonnet in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de psychopathologie du développement, Bron, France
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Centre de biologie et pathologie Est, Service d’hormonologie, d’endocrinologie moléculaire et des maladies rares, Bron, France
Search for other papers by Mathias Winter in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Centre de biologie et pathologie Est, Service d’hormonologie, d’endocrinologie moléculaire et des maladies rares, Bron, France
Search for other papers by Delphine Mallet in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service Endocrinologie Moléculaire et Maladies Rares, Bron, France
Search for other papers by Ingrid Plotton in
Google Scholar
PubMed
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
Search for other papers by Maryse Cartigny in
Google Scholar
PubMed
Search for other papers by Laetiti Martinerie in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
Search for other papers by Anne Bachelot in
Google Scholar
PubMed
Search for other papers by Frédéric Huet in
Google Scholar
PubMed
Search for other papers by Sabine Baron in
Google Scholar
PubMed
Search for other papers by Muriel Houang in
Google Scholar
PubMed
Search for other papers by Sylvie Soskin in
Google Scholar
PubMed
Search for other papers by Anne Lienhardt in
Google Scholar
PubMed
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Search for other papers by Cyril Amouroux in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
Search for other papers by Aurore Bouty in
Google Scholar
PubMed
Search for other papers by Lise Duranteau in
Google Scholar
PubMed
Search for other papers by Rémi Besson in
Google Scholar
PubMed
Search for other papers by Alaa El Ghoneimi in
Google Scholar
PubMed
Search for other papers by Dinane Samara-Boustani in
Google Scholar
PubMed
Search for other papers by François Becmeur in
Google Scholar
PubMed
Search for other papers by Nicolas Kalfa in
Google Scholar
PubMed
Search for other papers by Françoise Paris in
Google Scholar
PubMed
Search for other papers by François Medjkane in
Google Scholar
PubMed
Hospices Civils de Lyon, Groupement Hospitalier Est, Service d’endocrinologie, Bron, France
Search for other papers by Aude Brac de la Perrière in
Google Scholar
PubMed
Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
Search for other papers by Patricia Bretones in
Google Scholar
PubMed
Université Claude Bernard, Lyon, France
Search for other papers by Hervé Lejeune in
Google Scholar
PubMed
Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
Université Claude Bernard, Lyon, France
Search for other papers by Marc Nicolino in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
Université Claude Bernard, Lyon, France
Search for other papers by Pierre Mouriquand in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
Search for other papers by Daniela-Brindusa Gorduza in
Google Scholar
PubMed
Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
Search for other papers by Claire-Lise Gay in
Google Scholar
PubMed
the wake of the 2006 Chicago Consensus and other recent professional guidelines ( 1 , 33 , 34 , 35 , 36 ). In particular, a clear trend has been observed in favor of rearing newborns and infants diagnosed with SRD5A2 or HSD17B3 deficiencies as boys
Search for other papers by Tristan Avril in
Google Scholar
PubMed
Search for other papers by Quentin Hennocq in
Google Scholar
PubMed
Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Search for other papers by Juliane Leger in
Google Scholar
PubMed
Search for other papers by Dominique Simon in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
, CHD7, SEMA3A, NSMF, HS6ST1, FSHB, LHB, SOX3, FGF17, IL17RD, DUSP6, SPRY4, FLRT3, FEZF1, IGSF10, and TSHZ1 . The genes investigated in the CPHD were PROP1, NR0B1, PCSK1, LHX4, HESX1, OTX2, RNF216, OTUD4, SOX2, POU1F1, SOX10, PNPLA6, STUB1, POLR3A
Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Helene Bandsholm Leere Tallaksen in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Emma B Johannsen in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Jesper Just in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Mette Hansen Viuff in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed
and 95% of the expression levels seen from Xa ( 6 , 7 ). The genes in the pseudoautosomal region 1 (PAR1) ( AKAP17A , ASMT , ASMTL , CD99 , CD99P1 , CRLF2 , CSF2RA , DHRSX , GTPBP6 , IL3RA , P2RY8,PLCXD1 , PPP2R3B , SHOX , SLC25A6 , XG
Search for other papers by Yasmin Shibli Abu Raya in
Google Scholar
PubMed
Search for other papers by Asaf Bilgory in
Google Scholar
PubMed
Search for other papers by Nardin Aslih in
Google Scholar
PubMed
Search for other papers by Yuval Atzmon in
Google Scholar
PubMed
Search for other papers by Maya Shavit in
Google Scholar
PubMed
Search for other papers by Daniela Estrada in
Google Scholar
PubMed
Search for other papers by Moamina Sharqawi in
Google Scholar
PubMed
Ruth and Bruce Rappaport School of Medicine, The Technion Institute of Technology, Haifa, Israel
Search for other papers by Einat Shalom-Paz in
Google Scholar
PubMed
fresh transfers. Similarly, only one blastocyst was transferred in frozen blastocyst cycles. Luteal phase support included either oral dydrogesterone 10 mg TID (Duphastone Abbott, Chicago, IL, USA), vaginal micronized progesterone (MVP) 100 mg TID
Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden
Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden
Search for other papers by Angel Elenkov in
Google Scholar
PubMed
Search for other papers by Irene Leijonhufvud in
Google Scholar
PubMed
Search for other papers by Katerina Vaporidi in
Google Scholar
PubMed
Search for other papers by Åsa Tivesten in
Google Scholar
PubMed
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Wojdasiewicz P Wajda A Haladyj E Romanowska-Prochnicka K Felis-Giemza A Nalecz-Janik J Walczyk M Olesinska M Tarnacka B Paradowska-Gorycka A . IL-35, TNF-alpha, BAFF, and VEGF serum levels in patients with different rheumatic diseases